Professor Lee Eun-kyung of National Cancer Center, Simultaneously Awarded Hyangseol Young Researcher Award and EnM Academic Award

Professor Eun-Kyung Lee of the Thyroid Cancer Center at the National Cancer Center simultaneously received the ‘Hyangseol Young Researcher Award’ and the ‘EnM Academic Award.’

Professor Eun-Kyung Lee, Thyroid Cancer Center, National Cancer Center
[Photo by National Cancer Center]

The Hyangseol Young Researcher Award was established to honor the achievements of Dr. Seokjo Hyangseol and is given to endocrinologists under the age of 45 who have published outstanding papers with high academic value and contribution in the past three years. The EnM Academic Award is presented annually to members who have submitted papers demonstrating excellent research results to 'EnM (Endocrinology and Metabolism),' the official journal of the Korean Endocrine Society. This award ceremony took place at the ‘Korean Endocrine Society International Conference SICEM 2023,’ held from May 26 to 28 at the Lotte World Hotel in Jamsil, Seoul.

At this conference, Professor Eun-Kyung Lee was selected for the Hyangseol Young Researcher Award in recognition of the originality and excellence of her research titled ‘Automatic thyroid histopathology classification and prediction of molecular risk group based on artificial intelligence technology.’ She was also recognized with the EnM Academic Award for publishing the paper ‘Survival Comparison of Incidentally Found versus Clinically Detected Thyroid Cancers: An Analysis of a Nationwide Cohort Study’ in EnM.

Professor Lee said, “This award is the result of 20 years of effort to provide optimal treatment for thyroid cancer patients,” and added, “I will use this award as an opportunity to further dedicate myself to improving treatment methods for thyroid cancer patients and applying research results to clinical practice.”

Professor Eun-Kyung Lee, an endocrinologist at the Thyroid Cancer Center of the National Cancer Center, has been conducting targeted therapy and clinical trials of new drugs for progressive and refractory thyroid cancer. She is engaged in various thyroid cancer research projects, including the National Cancer Center’s public interest cancer research projects, external commissioned research projects of the Korea Health Industry Development Institute, and multinational clinical trials of new drugs.

This content was produced with the assistance of AI translation services.